R

Repertoire Immune Medicines

89 employees

Repertoire Immune Medicines is a clinical stage biotechnology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Life Science

Date founded

2020

Funding rounds raised

Total raised

$189M

from 6 investors over 6 rounds

R

Repertoire Immune Medicines raised $189M on April 13, 2021

Investors: Alaska Permanent Fund Corporation, The Invus Group, SoftBank Investment Advisers and Flagship Ventures

R

Repertoire Immune Medicines raised undisclosed on March 25, 2020

Investors: JDRF T1D Fund

R

Repertoire Immune Medicines raised $25M on November 14, 2017

Investors: Flagship Ventures

FAQ